Close Menu

NEW YORK (GenomeWeb) – Roche today said that it has signed a definitive agreement to acquire Flatiron Health, a maker of oncology-focused electronic health records.

Roche already held a nearly 13 percent stake in the New York City-based firm through an earlier investment. It said that it will pay $1.9 billion to Flatiron Health to close the deal, which is expected to occur in the first half of this year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.